Barnett R, Grace M, Boothe P, Latozek K, Neal C, Legatt D et al. Flumazenil in drug overdose: randomized, placebo-controlled study to assess cost effectiveness. Crit Care Med. 1999;27(1):78-81.
Bartlett D. The coma cocktail: indications, contraindications, adverse effects, proper dose, and proper route. J Emerg Nurs. 2004;30(6):572-4.
Boccuzzi-Chmura L, Robertson DC. Flumazenil (romazicon) and the patient with benzodiazepine overdose: risks versus benefits. J Emerg Nurs. 1996;22(4):330-3.
Buckley NA, Dawson AH, Juurlink DN, Isbister GK. Who gets antidotes? choosing the chosen few. Br J Clin Pharmacol. 2016;81(3):402-7.
Chern CH, Chern TL, Hu SC, Lee CH, Deng JF. Complete and partial response to flumazenil in patients with suspected benzodiazepine overdose. Am J Emerg Med. 1995;13(3):372-5.
Clancy C. Cardiologic principles I: Electrophysiologic and electrocardiographic principles. En: Lewis S. Nelson, Mary Ann Howland, Neal A. Lewin, Silas W. Smith, Lewis R. Goldfrank, Robert S. Hoffman. Goldfrank's Toxicologic Emergencies, Eleventh Edition; 2019, p. 255.
Farcas I, Schölin L, Eddleston M. Could Flumazenil Be Used Pre-hospital by Intramuscular Injection for Coma due to Mixed Drug Overdose Not Responding to Naloxone?: A Systematic Review of the Evidence. Basic Clin Pharmacol Toxicol. 2025;136(3):70007.
García Peláez M, Martínez Sánchez L. Guía de actualización de antídotos en indicaciones toxicológicas. En: Nogué Xarau S, Salgado García EJ, Martínez Sánchez L. Nogué. Toxicología clínica, 2ª ed. Barcelona. 2025, p. 253-268.
Greller H, Gupta A. Benzodiazepine poisoning. En: UpToDate (Última actualización Enero 2024).
Gunja N. The clinical and forensic toxicology of Z-drugs. J Med Toxicol. 2013;9(2):155-62.
Hoffman RS, Goldfrank LR. The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. JAMA. 1995;274(7):562-9.
Howland MA. Antidotes in depth: Flumazenil. En: Lewis S. Nelson, Mary Ann Howland, Neal A. Lewin, Silas W. Smith, Lewis R. Goldfrank, Robert S. Hoffman. Goldfrank's Toxicologic Emergencies, Eleventh Edition; 2019, p. 1094-1098.
Lavonas EJ, Akpunonu PD, Arens AM, Babu KM, Cao D, Hoffman RS et al; American Heart Association. 2023 American Heart Association Focused Update on the Management of Patients With Cardiac Arrest or Life-Threatening Toxicity Due to Poisoning: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2023;148(16):149-184.
Martínez Sánchez L, López Ávila J, Barasoain Millán A, Angelats Romero CM, Azkunaga Santibañez B, Molina Cabañero JC. Grupo de Trabajo de Intoxicaciones de la Sociedad Española de Urgencias de Pediatría. Acciones que no hay que hacer ante un paciente que ha contactado con un posible tóxico. 2021;94(5):285-292.
McDuffee AT & Tobias JD. Seizure after flumazenil administration in a pediatric patient. Pediatr Emerg Care. 1995; 11:186-187.
Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Pharmacol. 2008;(182):335-60.
Penninga EI, Graudal N, Ladekarl MB, Jürgens G. Adverse Events Associated with Flumazenil Treatment for the Management of Suspected Benzodiazepine Intoxication-A Systematic Review with Meta-Analyses of Randomised Trials. Basic Clin Pharmacol Toxicol. 2016;118(1):37-44.
Perry HE, Shannon MW. Diagnosis and management of opioid- and benzodiazepine-induced comatose overdose in children. Curr Opin Pediatr. 1996;8(3):243-7.
Rama B. Rao. Neurologic principles. En: Lewis S. Nelson, Mary Ann Howland, Neal A. Lewin, Silas W. Smith, Lewis R. Goldfrank, Robert S. Hoffman. Goldfrank's Toxicologic Emergencies, Eleventh Edition; 2019, p. 344.
Razavizadeh AS, Zamani N, Ziaeefar P, Ebrahimi S, Hassanian-Moghaddam H. Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial. Eur J Clin Pharmacol. 2021;77(4):547-554.
Seger DL. Flumazenil--treatment or toxin. J Toxicol Clin Toxicol. 2004;42(2):209-16.
Sivilotti ML. Flumazenil, naloxone and the 'coma cocktail'. Br J Clin Pharmacol. 2016;81(3):428-36.
Smith SW. Drugs and pharmaceuticals: management of intoxication and antidotes. EXS. 2010;100:397-460.
Thomson JS, Donald C, & Lewin K. Use of Flumazenil in benzodiazepine overdose. Emerg Med J. 2006; 23(2):162.
Veiraiah A, Dyas J, Cooper G, Routledge PA, Thompson JP. Flumazenil use in benzodiazepine overdose in the UK: a retrospective survey of NPIS data. Emerg Med J. 2012;29(7):565-9.
Weinbroum AA, Flaishon R, Sorkine P, Szold O, Rudick V. A risk-benefit assessment of flumazenil in the management of benzodiazepine overdose. Drug Saf. 1997;17(3):181-96.
Weinbroum A, Rudick V, Sorkine P, Nevo Y, Halpern P, Geller E et al. Use of flumazenil in the treatment of drug overdose: a double-blind and open clinical study in 110 patients. Crit Care Med. 1996;24(2):199-206.
Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL et al. Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(3):203-33.
Zamani N, Hassanian-Moghaddam H, Zamani N. Strategies for the treatment of acute benzodiazepine toxicity in a clinical setting: the role of antidotes. Expert Opin Drug Metab Toxicol. 2022;18(6):367-379.
